share_log

Form 144 | Entrada Therapeutics(TRDA.US)高管拟出售8,510股股份,价值约11.01万美元

Form 144 | Entrada Therapeutics(TRDA.US) Officer Proposes to Sell 110.1K in Common Stocks

moomoo News ·  Apr 11 16:26

SEC FILLINGS DISCLOSED/ Apr 11, $Entrada Therapeutics (TRDA.US)$ Officer NERISSA C KREHER intends to sell 8,510 shares of its common stock on Apr 11, with a total market value of approximately $110.1K.

NERISSA C KREHER has reduced shareholding in $Entrada Therapeutics (TRDA.US)$ by 35,448 shares since Apr 5, 2024, with a total value of approximately $463.45K.

1712867208100650609.png

What is Form 144?

Form 144: Notice of Proposed Sale of Securities is a document issued by the Securities and Exchange Commission (SEC). Individuals such as executive officers and affiliates of a US-listed company must submit this form to the SEC when they intend to sell more than 5,000 shares or units of that company's stock, or if the sale price adds up to more than $50,000 in any three-month period. This regulation is known as Rule 144, under the Securities Act of 1933.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment